Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network.

Sara Y TartofFagen XieRuchi YadavKaren J WernliEmily T MartinEdward A BelongiaManjusha GaglaniRichard K ZimmermanH Keipp TalbotNatalie J ThornburgBrendan FlanneryJessie R Chungnull null

Published in: medRxiv : the preprint server for health sciences (2023)

Three mRNA COVID-19 vaccine doses provided additional protection against SARS-CoV-2 Omicron variant-associated illness among previously infected participants.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
randomized controlled trial
systematic review
binding protein